Dr. Sehouli on Considering Secondary Cytoreductive Surgery in Ovarian Cancer

Jalid Sehouli, MD
Published: Friday, Nov 10, 2017



Jalid Sehouli, MD, professor, director of the Clinic Campus Virchow and Campus Benjamin Franklin Charité Center Gynecology, Charité – Universitatsmedizin Berlin, advises physicians on considering secondary cytoreductive surgery in ovarian cancer.

Sehouli’s advice for physicians that are considering secondary cytoreductive surgery for their patients is to take in account previous treatment, tumor pattern, and symptoms. From there, they must define a treatment goal and consider the infrastructure of their institution.
 
SELECTED
LANGUAGE


Jalid Sehouli, MD, professor, director of the Clinic Campus Virchow and Campus Benjamin Franklin Charité Center Gynecology, Charité – Universitatsmedizin Berlin, advises physicians on considering secondary cytoreductive surgery in ovarian cancer.

Sehouli’s advice for physicians that are considering secondary cytoreductive surgery for their patients is to take in account previous treatment, tumor pattern, and symptoms. From there, they must define a treatment goal and consider the infrastructure of their institution.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Community Practice Connections™: Show Me the Data™: Leveraging Evidence to Optimize Applications of PARP Inhibitor Strategies in Ovarian CancerJun 29, 20191.5
Publication Bottom Border
Border Publication
x